Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Tandem duplicator phenotypes define 50% of triple negative breast cancers

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 07.12.17
Views: 1206
Rating:

Dr Ed Liu - The Jackson Laboratory, Bar Harbor, USA

Dr Ed Liu speaks with ecancer at SABCS 2017 about the tandem duplicator phenotype as a distinct genomic configuration in cancer.

He describes how next-generation sequencing studies have revealed genome-wide structural variation patterns in cancer, such as chromothripsis and chromoplexy, that do not engage a single discernable driver mutation, and whose clinical relevance is unclear.

Dr Liu devised a robust genomic metric able to identify cancers with a chromotype called tandem duplicator phenotype (TDP) characterised by frequent and distributed tandem duplications (TDs).

He concludes that TDP is a common cancer chromotype that coordinately alters oncogene/tumour suppressor expression with potential as a marker for chemotherapeutic response.

Related videos

follow us

Breast Cancer CDK 4/6


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation